Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Karen van der Meulen"'
Autor:
Kathlyn Laval, Katrien C. K. Poelaert, Jolien Van Cleemput, Jing Zhao, Annelies P. Vandekerckhove, Annick C. Gryspeerdt, Barbara Garré, Karen van der Meulen, Hossein B. Baghi, Haileleul N. Dubale, Ines Zarak, Eline Van Crombrugge, Hans J. Nauwynck
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
Equine herpesvirus type 1 (EHV-1) is an alphaherpesvirus related to pseudorabies virus (PRV) and varicella-zoster virus (VZV). This virus is one of the major pathogens affecting horses worldwide. EHV-1 is responsible for respiratory disorders, aborti
Externí odkaz:
https://doaj.org/article/eb6db2da8f814204b98b69bbfec9f161
Publikováno v:
Applied Biosafety.
Autor:
Karen van der Meulen, Ines Zarak, Annelies P. Vandekerckhove, Kathlyn Laval, Hossein Bannazadeh Baghi, Jing Zhao, Jolien Van Cleemput, Katrien C K Poelaert, Annick Gryspeerdt, Barbara Garré, Haileleul N Dubale, Eline Van Crombrugge, Hans Nauwynck
Publikováno v:
Frontiers in Microbiology, Vol 12 (2021)
FRONTIERS IN MICROBIOLOGY
Frontiers in Microbiology
FRONTIERS IN MICROBIOLOGY
Frontiers in Microbiology
Equine herpesvirus type 1 (EHV-1) is an alphaherpesvirus related to pseudorabies virus (PRV) and varicella-zoster virus (VZV). This virus is one of the major pathogens affecting horses worldwide. EHV-1 is responsible for respiratory disorders, aborti
Publikováno v:
Influenza and Other Respiratory Viruses
Background H3N2 influenza viruses circulating in humans and European pigs originate from the pandemic A/Hong Kong/68 virus. Because of slower antigenic drift in swine, the antigenic divergence between swine and human viruses has been increasing. It r
Autor:
Rafael Pedrazuela Sanz, Hans Nauwynck, Caroline Bonckaert, Mar Fenech Martinez, Karen van der Meulen, Isaac Rodríguez-Ballarà
Publikováno v:
Porcine Health Management
PORCINE HEALTH MANAGEMENT
PORCINE HEALTH MANAGEMENT
Background: Western European porcine reproductive and respiratory syndrome virus (PRRSV) strains cause limited and mild clinical signs whereas more virulent strains are circulating in Eastern Europe. The emergence of such highly virulent strains in W
Publikováno v:
Veterinary Immunology and Immunopathology. 111:31-40
Equine herpesvirus (EHV)-1 is a pathogen of horses, well known for its ability to induce abortion and nervous system disorders. Clinical signs may occur despite the presence of a virus-specific immune response in the horse. The current review will su
Publikováno v:
Veterinary Microbiology. 113:265-273
In vitro studies demonstrated that most equine herpesvirus 1 (EHV-1)-infected peripheral blood mononuclear cells (PBMC) do not expose viral envelope proteins on their surface. This protects them against antibody-dependent lysis. We examined whether v
Autor:
Karen van der Meulen, Andrew C. Breed, Marion Koopmans, Barbara Wieland, R. Kosmider, Sophie von Dobschuetz, Ian H. Brown, Sylvie van der Werf, Marco De Nardi, Erwin de Bruin, D. J. Alexander, Kristien Van Reeth, Gudrun S. Freidl, Gwen Dauphin, Jill Banks, A. Hill, Ilaria Capua, Kate Harris, Vincent Enouf, Olga Munoz, Adam Meijer, Katharina D.C. Stärk, Kim B. Stevens
Publikováno v:
EcoHealth
EcoHealth, 2017, 14 (2), pp.342-360. ⟨10.1007/s10393-017-1244-y⟩
EcoHealth, 14(2), 342-360. Springer New York
EcoHealth, 2017, 14 (2), pp.342-360. ⟨10.1007/s10393-017-1244-y⟩
EcoHealth, 14(2), 342-360. Springer New York
Drivers and risk factors for Influenza A virus transmission across species barriers are poorly understood, despite the ever present threat to human and animal health potentially on a pandemic scale. Here we review the published evidence for epidemiol
Publikováno v:
Microbiology. 81:21-25
In the present study, the outcome of an inoculation of equine peripheral blood mononuclear cells (PBMC) with equine herpesvirus type 1 (EHV-1) was studiedin vitro. Cytoplasmic and plasma membrane expression of viral antigens, intra- and extracellular
Publikováno v:
Vaccine
Ghent University Academic Bibliography
Ghent University Academic Bibliography
The efficacy of a commercial attenuated European subtype 1 PRRSV vaccine was evaluated upon challenge with the East European subtype 3 PRRSV strain Lena (83.3% nucleotide identity). Two vaccination experiments were carried out. Four- and seven-week-o